GDXGAHYCCRLYQK-ANYOKISRSA-N
C32H38ClF3N8O3 — CID 146625059
Data last refreshed: (MolForge compound catalog, from PubChem)
About GDXGAHYCCRLYQK-ANYOKISRSA-N
GDXGAHYCCRLYQK-ANYOKISRSA-N (PubChem CID 146625059) has the molecular formula C32H38ClF3N8O3 and a molecular weight of 675.16 g/mol. Its IUPAC name is tert-butyl 4-[7-[6-amino-4-methyl-3-(trifluoromethyl)-2-pyridinyl]-6-chloro-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]-2-(cyanomethyl)piperazine-1-carboxylate.
Molecular Properties
| Compound Name | GDXGAHYCCRLYQK-ANYOKISRSA-N |
|---|---|
| PubChem CID | 146625059 |
| Molecular Formula | C32H38ClF3N8O3 |
| Molecular Weight | 675.16 g/mol |
| Exact Mass | 674.27 |
| IUPAC Name | tert-butyl 4-[7-[6-amino-4-methyl-3-(trifluoromethyl)-2-pyridinyl]-6-chloro-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]-2-(cyanomethyl)piperazine-1-carboxylate |
| SMILES | Cc1cc(N)nc(-c2cc3nc(OC[C@@H]4CCCN4C)nc(N4CCN(C(=O)OC(C)(C)C)C(CC#N)C4)c3cc2Cl)c1C(F)(F)F |
| InChI | InChI=1S/C32H38ClF3N8O3/c1-18-13-25(38)40-27(26(18)32(34,35)36)21-15-24-22(14-23(21)33)28(41-29(39-24)46-17-20-7-6-10-42(20)5)43-11-12-44(19(16-43)8-9-37)30(45)47-31(2,3)4/h13-15,19-20H,6-8,10-12,16-17H2,1-5H3,(H2,38,40)/t19?,20-/m0/s1 |
| InChIKey | GDXGAHYCCRLYQK-ANYOKISRSA-N |
| XLogP | 6.07 |
| TPSA | 133.73 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 675.16 |
| LogP ≤ 5 | 6.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146625059 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.